Capecitabine, DNA/RNA Synthesis Inhibitor

Por um escritor misterioso

Descrição

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine-d11, Stable Isotope
Capecitabine, DNA/RNA Synthesis Inhibitor
Cancer & Cancer Drug
Capecitabine, DNA/RNA Synthesis Inhibitor
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Capecitabine, DNA/RNA Synthesis Inhibitor
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Capecitabine, DNA/RNA Synthesis Inhibitor
Chemotherapy
Capecitabine, DNA/RNA Synthesis Inhibitor
XELODA® - Cancer Therapy Advisor
Capecitabine, DNA/RNA Synthesis Inhibitor
Frontiers PARP inhibitors combined with radiotherapy: are we ready?
Capecitabine, DNA/RNA Synthesis Inhibitor
A simplified map of 5-fluorouracil and capecitabine metabolism and
Capecitabine, DNA/RNA Synthesis Inhibitor
Oxaliplatin, CAS#:63121-00-6
Capecitabine, DNA/RNA Synthesis Inhibitor
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside
de por adulto (o preço varia de acordo com o tamanho do grupo)